Edition:
United Kingdom

Sawai Pharmaceutical Co Ltd (4555.T)

4555.T on Tokyo Stock Exchange

5,470JPY
22 May 2019
Change (% chg)

¥90 (+1.67%)
Prev Close
¥5,380
Open
¥5,450
Day's High
¥5,500
Day's Low
¥5,410
Volume
254,000
Avg. Vol
197,062
52-wk High
¥6,660
52-wk Low
¥4,690

Latest Key Developments (Source: Significant Developments)

R&I removes Sawai Pharmaceutical from rating monitor and affirms its rating at "A-"-R&I
Tuesday, 3 Apr 2018 

April 3 (Reuters) - Sawai Pharmaceutical Co Ltd <4555.T>:Rating and Investment Information, Inc. (R&I) removed the company from rating monitor-R&I.Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A-"-R&I.Rating outlook stable-R&I.  Full Article

SAWAI PHARMACEUTICAL says details of shares private placement
Thursday, 21 Dec 2017 

Dec 21 (Reuters) - SAWAI PHARMACEUTICAL Co Ltd <4555.T> ::Says it plans to issue 900,000 million new shares at totaling 4.27 billion yen with subscription date on Dec. 25 and payment date on Dec. 26.  Full Article

Sawai Pharmaceutical says share prices
Tuesday, 5 Dec 2017 

Dec 5 (Reuters) - Sawai Pharmaceutical Co Ltd <4555.T>:Says it will issue new shares via public offering, with the issue price of 4,947 yen per share (24.74 billion yen in total) and paid-in price of 4,743 yen per share (23.72 billion yen in total) .Says it will distribute shares via public offering, with paid-in price of 4,743 yen per share (4.74 billion yen in total).Says it will issue new shares via private placement, with paid-in price of 4,743 yen per share (up to 4.27 billion yen in total) .The previous plan was disclosed on Nov. 27 .  Full Article

Sawai Pharmaceutical to issue new shares and to distribute treasury common stock
Monday, 27 Nov 2017 

Nov 27(Reuters) - Sawai Pharmaceutical Co Ltd <4555.T>:Says it plans to issue 5 million new shares and to distribute 1 million shares of its treasury common stock through public offering .Says it plans to issue 900,000 new shares through private placement to SMBC Nikko Securities Inc., with subscription date on Dec. 25 and payment date on Dec. 26.Proceeds to be used for loan repayment .  Full Article

Sawai Pharmaceutical to sell 20 pct stake in SAWAI AMERICA for $211 mln
Monday, 13 Nov 2017 

Nov 13(Reuters) - Sawai Pharmaceutical Co Ltd <4555.T>:Says it plans to sell 20 percent stake in a wholly owned U.S.-based unit SAWAI AMERICA INC to Sumitomo Corporation of Americas, a wholly owned unit of SUMITOMO CORPORATION <<<8053.T>>>, for $211 million (23.2 billion yen).Transaction will be completed as of the end of March 2018.  Full Article

Upsher-Smith says parent co to manufacture migraine medication in Japan With AstraZeneca
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Upsher-Smith Laboratories LLC::Upsher-Smith Laboratories says co's parent Sawai Pharmaceutical entered agreement with AstraZeneca to manufacture & market migraine medication in Japan​.Upsher-Smith Laboratories​ - agreement is to ‍manufacture, market Zomig (zolmitriptan) Tablets 2.5 mg & Zomig (zolmitriptan) Rapid Melt (RM) Tablets 2.5 mg.Upsher-Smith Labs - ‍under agreement, Sawai expected to take manufacturing, marketing of Zomig​ products in Japan by mid-2018 from AstraZeneca K.K.  Full Article

Sawai Pharmaceutical completes acquisition of Upsher-Smith Laboratories for $1.05 bln
Thursday, 1 Jun 2017 

June 1(Reuters) - Sawai Pharmaceutical Co Ltd <4555.T>:Says it acquired U.S.-based company Upsher-Smith Laboratories, LLC, which is engaged in manufacture and sales of generic drug, for $1.05 billion (about 116.5 billion yen), on May 31 (U.S. local time).Acquisition plan was announced on April 20.  Full Article